SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-182719
Filing Date
2017-05-25
Accepted
2017-05-25 08:47:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d403510d424b5.htm 424B5 397250
2 GRAPHIC g403510g10b61.jpg GRAPHIC 23917
3 GRAPHIC g403510g55k40.jpg GRAPHIC 97828
4 GRAPHIC g403510g98e51.jpg GRAPHIC 96192
  Complete submission text file 0001193125-17-182719.txt   698862
Mailing Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451
Business Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-217172 | Film No.: 17868370
SIC: 2834 Pharmaceutical Preparations